Difference between revisions of "WSI21-139-Case-4"

From MGH Learn Pathology
Line 22: Line 22:
 
|frames=1
 
|frames=1
 
|type=image
 
|type=image
|subject=Z0FBQUFBQmg2eG5mWWNTR19lSkllYVptR2pfUFZVSzZUcURkWmptaFY3MUt6X2Rwb3lJY1VyN0pDNFdnbF9xb1NHMGE2bUtYcURzZmM3ZTd3QWJyNV93Mnk0MXBWczlfNlE9PQ
+
|subject=Z0FBQUFBQmloU1gxZndoQ3p1eGFBaVZFanhWbkJFREdfNkh1bUlBbG9vc0tyamRjQWJUOVdfNzRwMnEzSUxKcHI0OGZZM3k3QkdKdG9YbFNOT2JUTDFPQWVwaDdTWXY4anc9PQ
 
|reasonCode=Papanicolaou
 
|reasonCode=Papanicolaou
 
|view=show
 
|view=show

Revision as of 11:59, May 18, 2022

WSI21-139-Case-4
lytic appearing osseous lesion and omental lesion (this sample)
Low grade B cell lymphoma (Follicular Lymphoma)
No results